JAK2 and acquired polycythemia vera: Therapeutic phlebotomy, albeit effective in a temporary decrease in HCT, does not produce a disease-modifying effect as HCT is ultimately again increased, requiring additional therapeutic phlebotomy, and most PV patients experience a progressive increase in the allele burden of the mutant JAK2 clone over time.